Pembrolizumab-induced sarcoid-like reaction (c.2019) is a phenomenon which has been associated with the use of the programmed cell death protein 1 (PD1) inhibitor pembrolizumab. It could be mistaken for metastatic disease in some situations.
At the time the article was created Yuranga Weerakkody had no recorded disclosures.
View Yuranga Weerakkody's current disclosuresAt the time the article was last revised Arlene Campos had no financial relationships to ineligible companies to disclose.
View Arlene Campos's current disclosuresPembrolizumab-induced sarcoid-like reaction (c.2019) is a phenomenon which has been associated with the use of the programmed cell death protein 1 (PD1) inhibitor pembrolizumab. It could be mistaken for metastatic disease in some situations.
ADVERTISEMENT: Supporters see fewer/no ads
Updating… Please wait.
Unable to process the form. Check for errors and try again.
Thank you for updating your details.